Mandate

Vinge advises Verisure Securitas Direct

October 13, 2016

Vinge is advising Verisure Securitas Direct in connection with the entry into of a co-operation with Falck regarding alarm services in Denmark and Norway.

As part of the co-operation, Verisure Securitas Direct has acquired an alarm services portfolio in Norway, Denmark and Sweden from Falck. Verisure Securitas Direct is a leading global supplier of connected home burglar alarm and fire alarm services as well as smart functionality for homes and businesses. Completion of the transaction is subject to approval by the salient public authorities.

Vinge’s team consisted of, among others, partner Jonas Bergström, counsel Mattias Pannier and associate Michaela Cronemyr.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024